Back to School: How biopharma can reboot drug development. Access exclusive analysis here

cobas KRAS Mutation Test regulatory update

The U.K.'s NICE issued draft guidance recommending 2 PCR-based tests to determine K-Ras (KRAS) mutation status in adults with metastatic colorectal cancer (mCRC). The committee backed

Read the full 261 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE